84 related articles for article (PubMed ID: 23089587)
1. Copeptin: a marker for stress reaction in fetuses with intrauterine growth restriction.
Burkhardt T; Schwabe S; Morgenthaler NG; Natalucci G; Zimmermann R; Wellmann S
Am J Obstet Gynecol; 2012 Dec; 207(6):497.e1-5. PubMed ID: 23089587
[TBL] [Abstract][Full Text] [Related]
2. Plasma copeptin may not be a sensitive marker of perinatal stress in healthy full-term growth-restricted fetuses.
Briana DD; Boutsikou M; Boutsikou T; Dodopoulos T; Gourgiotis D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):705-709. PubMed ID: 27125294
[TBL] [Abstract][Full Text] [Related]
3. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
Koch L; Dabek MT; Frommhold D; Poeschl J
Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
[TBL] [Abstract][Full Text] [Related]
4. Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes.
Smith J; Halse KG; Damm P; Lindegaard ML; Amer-Wåhlin I; Hertel S; Johansen M; Mathiesen ER; Nielsen LB; Goetze JP
Biomark Med; 2013 Feb; 7(1):139-46. PubMed ID: 23387495
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular biomarkers in paired maternal and umbilical cord blood samples at term and near term delivery.
Blohm ME; Arndt F; Sandig J; Diehl W; Zeller T; Mueller GC; Schlesner C; Mir TS; Blankenberg S; Hecher K; Singer D; Weil J
Early Hum Dev; 2016 Mar; 94():7-12. PubMed ID: 26851448
[TBL] [Abstract][Full Text] [Related]
6. High copeptin concentrations in umbilical cord blood after vaginal delivery and birth acidosis.
Wellmann S; Benzing J; Cippà G; Admaty D; Creutzfeldt R; Mieth RA; Beinder E; Lapaire O; Morgenthaler NG; Haagen U; Szinnai G; Bührer C; Bucher HU
J Clin Endocrinol Metab; 2010 Nov; 95(11):5091-6. PubMed ID: 20702521
[TBL] [Abstract][Full Text] [Related]
7. Gender and renal function influence plasma levels of copeptin in healthy individuals.
Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
[TBL] [Abstract][Full Text] [Related]
8. Maternal and neonatal copeptin levels at cesarean section and vaginal delivery.
Foda AA; Abdel Aal IA
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):215-8. PubMed ID: 22921847
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth.
Ostlund E; Tally M; Fried G
Obstet Gynecol; 2002 Sep; 100(3):567-73. PubMed ID: 12220780
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.
Belting M; Almgren P; Manjer J; Hedblad B; Struck J; Wang TJ; Bergmann A; Melander O
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):513-22. PubMed ID: 22267286
[TBL] [Abstract][Full Text] [Related]
11. Cord blood copeptin concentrations in fetal macrosomia.
Briana DD; Baka S; Boutsikou M; Boutsikou T; Xagorari M; Gourgiotis D; Malamitsi-Puchner A
Metabolism; 2016 Jan; 65(1):89-94. PubMed ID: 26477270
[TBL] [Abstract][Full Text] [Related]
12. Biochemical tissue-specific injury markers of the heart and brain in postpartum cord blood.
Kocylowski RD; Dubiel M; Gudmundsson S; Sieg I; Fritzer E; Alkasi O; Breborowicz GH; von Kaisenberg CS
Am J Obstet Gynecol; 2009 Mar; 200(3):273.e1-273.e25. PubMed ID: 19167692
[TBL] [Abstract][Full Text] [Related]
13. N-terminal parathyroid hormone-related protein levels in human intrauterine growth restricted pregnancies.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Marmarinos A; Iacovidou N; Malamitsi-Puchner A
Acta Obstet Gynecol Scand; 2007; 86(8):945-9. PubMed ID: 17653879
[TBL] [Abstract][Full Text] [Related]
14. Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction.
Lindqvist PG; Balogh I; Dahlbäck B
Acta Obstet Gynecol Scand; 2010; 89(1):22-6. PubMed ID: 19916876
[TBL] [Abstract][Full Text] [Related]
15. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
16. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
[TBL] [Abstract][Full Text] [Related]
17. Perinatal circulating visfatin levels in intrauterine growth restriction.
Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
[TBL] [Abstract][Full Text] [Related]
18. Copeptin is not a useful biomarker for small-for-gestational-age: a case control study.
Hansen AT; Sandager P; Uldbjerg N; Hvas AM
Scand J Clin Lab Invest; 2014 Nov; 74(8):687-92. PubMed ID: 25120188
[TBL] [Abstract][Full Text] [Related]
19. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
20. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth.
Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
